Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SB208 Phase 2 in Interdigital Tinea Pedis
NCT02860052Phase 2Completed
- Sponsor
- Novan
- Start
- Jul 2016
- Primary completion
- Jan 2017
- Modality
- Polymer-based Nanoparticles, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of berdazimer in tinea pedis, sponsored by Novan. Started Jul 2016; status: completed.
02
Drugs
berdazimer
03
Conditions
tinea pedis
Beyond the preview
Go deeper on NCT02860052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02860052.